Related Experiment Video
Updated: Mar 29, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Social Risk Adjustment and Bonus Eligibility in Medicare Advantage Star Ratings
Andrew Anderson1, Rajesh Satpathy-Horton1, Mark K Meiselbach1
1Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Importance:
The Medicare Advantage (MA) star ratings program determines eligibility for quality bonus payments that directly affect plan revenue, benefit generosity, and market competitiveness. To improve fairness, the Centers for Medicare & Medicaid Services (CMS) introduced the Categorical Adjustment Index (CAI) in 2017, which adjusts ratings based on enrollee social risk factors. How these adjustments have affected bonus eligibility for MA contracts over time remains unclear.
Objective:
To assess the association between CAI adjustments and bonus eligibility in the MA star ratings program and assess whether the policy supports fair comparisons in performance measurement.
Design, Setting, And Participants:
This retrospective cohort panel study included MA contracts with CMS star ratings data from 2014 to 2025, including at least 1 year before and after CAI implementation. Publicly available CMS files were used to merge contract-level CAI values and star ratings for overall, Part C, and Part D domains.
Exposures:
Annual CAI value (range: -0.10 to 0.20), assigned to MA contracts based on its proportion of beneficiaries who are dually eligible for Medicare and Medicaid or receive a low-income subsidy and those with disability status.
Main Outcomes And Measures:
Bonus eligibility, defined as an overall, Part C, or Part D star rating of 4.0 or higher. Fixed-effects linear regression models were used to assess the association between CAI value and bonus eligibility.
Results:
Of 339 contracts between 2017 and 2025, 156 (46.0%) became bonus eligible at least once due to CAI adjustments, leading to 398 CAI-based bonus eligibility transitions. Each 0.10-point increase in CAI value was associated with a 0.16-point increase in bonus eligibility probability (β = 1.41; 95% CI, 0.64-2.18; P < .001). Contracts with the highest CAI values remained less likely to achieve bonus eligibility even after adjustment.
Conclusions And Relevance:
The results of this study provide evidence on the potential role of CAI in MA contract performance; future research should assess whether alternative adjustment methods can create better comparisons of performance between MA contracts.
Related Concept Videos
Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preventive Healthcare Services
Hazard Ratio
For example, in a clinical trial...
Standards of Care I
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

